Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094679 · ClinicalTrials.gov registry record · Phase 3
Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia
A Phase 3 study of Amblyopia, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 189
- Enrollment target
- 1
- Study location
NCT00094679: Completed Phase 3 study of Amblyopia, sponsored by Jaeb Center for Health Research.
NCT00094679 is a Phase 3 study of Amblyopia that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 189 participants, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00094679, a Phase 3 study of Amblyopia, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 189 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this study are: * To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with minimal patching (2 hours) for moderate amblyopia. * To develop more precise estimates than currently available for the visual acuity improvement that occurs during treatment of amblyopia with patching. * To identify factors that may be associated with successful treatment of amblyopia with patching.
Conditions Studied
Interventions
- DEVICE Eye patch
Study Locations (1)
Maryland
- Wilmer Eye Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2001-05 |
| Est. Completion | 2002-09 |
| Phase | Phase 3 |
What the finished NCT00094679 record still lists
NCT00094679 is an interventional study that assigns participants to a tested intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 1 intervention - of which Eye patch is the first listed.
NCT00094679 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00094679 about?
NCT00094679 is a clinical study titled "Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia". The goals of this study are: * To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with minimal patching (2 hours) for moderate amblyopia. * To develop more precise estimates than currently available f...
What is the current status of trial NCT00094679?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 189 participants. The study started on 2001-05. Estimated completion is 2002-09.
What conditions does trial NCT00094679 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT00094679?
The interventions under investigation include: Eye patch (DEVICE).
Who is sponsoring clinical trial NCT00094679?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00094679 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00094679's enrollment target sits among peer trials
189 8th of 24 higher than 17 of 24 other Amblyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RECRUITING · Phase 3
-
Amblyopia (Lazy Eye) Treatment Study
COMPLETED · Phase 3
-
Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children
COMPLETED · Phase 3
-
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia